Receipt of Guideline-Concordant Care Lower for Black Colorectal Cancer Patients

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 14, 2023.

By Elana Gotkine HealthDay Reporter

TUESDAY, Nov. 14, 2023 -- Individuals racialized as Black and newly diagnosed with colorectal cancer (CRC) receive worse and less-timely guideline-concordant care, according to a study published online Nov. 8 in the Journal of Clinical Oncology.

Leticia M. Nogueira, Ph.D., M.P.H., from the American Cancer Society in Atlanta, and colleagues selected individuals aged 18 to 49 years racialized as non-Hispanic Black and White (self-identified) and newly diagnosed with CRC during 2004 to 2019. Individuals who received recommended care, which included staging, surgery, lymph node evaluation, chemotherapy, and radiotherapy, were considered to have received guideline-concordant care.

Overall, 20.8 and 14.5 percent of the 84,882 patients with colon cancer and 62,573 with rectal cancer, respectively, were racialized as Black. The researchers found that the likelihood of not receiving guideline-concordant care for colon and rectal cancers was increased for individuals racialized as Black (adjusted hazard ratios, 1.18 and 1.27, respectively). Among patients with colon and rectal cancer, 28.2 and 21.6 percent of the disparity, respectively, was explained by health insurance. Compared with individuals racialized as White, those racialized as Black had increased time to adjuvant chemotherapy for colon cancer and neoadjuvant chemoradiation for rectal cancer.

"With health insurance being the largest modifiable factor contributing to racial disparities in this study, it's critical to eliminate this barrier," Nogueira said in a statement. "Expanding access to health insurance coverage could help improve colorectal care and outcomes from individuals of all racialized groups."

Two authors disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-15 01:13

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords